The Function of Pre-Assessment in Surgery for Oesophageal Cancer
Abstract
National figures for oesophagectomy mortality in the United Kingdom have been steadily dropping (12% to 9%) since the late 1990’s.1 More recently, these figures have improved significantly as shown in the 2016 annual report of the UK National Oesophago-Gastric Cancer Audit (NOGCA), revealing a post-oesophagectomy 90-day mortality rate of 3.2%.
References
Al-Sarira AA, David G, Willmott S, Slavin JP, Deakin M, Corless DJ. Oesophagectomy practice and outcomes in England. Br J Surg. 2007; 94(5): 585-591. doi: 10.1002/bjs.5805
AUGIS. 2016 National Oesophago-gastric Cancer Audit [In-e2 Charalabopoulos A, et al ternet]. 2016. Web site. http://www.augis.org/national-oesopha-go-gastric-cancer-audit/. Accessed September 8, 2017.
Atkins BZ, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thor Surg. 2004; 78(4): 1170-1176. doi: 10.1016/j.athoracsur.2004.02.034
Cantlay KL, Baker S, Parry A, Danjoux G. The impact of a con-sultant anaesthetist led pre-operative assessment clinic on patients undergoing major vascular surgery. Anaesthesia. 2006; 61(3): 234- 239. doi: 10.1111/j.1365-2044.2005.04514.x
Hocking G, Shaikh L. Anaesthetic pre-assessment clinics to identify patients at risk. Anaesthesia. 2000; 55(8): 812-812. doi: 10.1046/j.1365-2044.2000.01629-3.x
Tegels JJ. Improving the outcomes in gastric cancer surgery. World J Gastroenterol. 2014; 20(38): 13692-13704. doi: 10.3748/wjg. v20.i38.13692
Bhagwat M, Paramesh K. Cardio-pulmonary exercise testing: An objective approach to pre-operative assessment to define level of perioperative care. Indian J Anaesth. 2010; 54(4): 286-291. doi: 10.4103/0019-5049.68369
Ra J, Paulson EC, Kucharczuk J, et al. Postoperative mortality after esophagectomy for cancer: Development of a preoperative risk prediction model. Ann Surg Oncol. 2008; 15(6): 1577-1584. doi: 10.1245/s10434-008-9867-4
Markar SR, Low DE. Physiology, not chronology, dictates out-comes after esophagectomy for esophageal cancer: Outcomes in patients 80 years and older. Ann Surg Oncol. 2013; 20(3): 1020-1026. doi: 10.1245/s10434-008-9867-4
Wagner D. Role of frailty and sarcopenia in predicting out-comes among patients undergoing gastrointestinal surgery. World J Gastrointest Surg. 2016; 8(1): 27-40. doi: 10.4240/wjgs.v8.i1.27
Moyes LH, McCaffer CJ, Carter RC, Fullarton GM, Mackay CK, Forshaw MJ. Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery. Ann R Coll Surg Engl. 2013; 95(2): 125-130. doi: 10.1308/rcsann.2013.95.2.125
Nagamatsu Y, Shima I, Yamana H, Fujita H, Shirouzu K, Ishitake T. Preoperative evaluation of cardiopulmonary reserve with the use of expired gas analysis during exercise testing in pa-tients with squamous cell carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg. 2001;121(6): 1064-1068. doi: 10.1067/ mtc.2001.113596
Li C, Carli F, Lee L, et al. Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: A pilot study. Surg Endosc. 2013; 27(4): 1072-1082. doi: 10.1007/ s00464-012-2560-5
Le Roy B, Selvy M, Slim K. The concept of prehabilitation: What the surgeon needs to know? J Visc Surg. 2016; 153(2): 109- 112. doi: 10.1016/j.jviscsurg.2016.01.001
Le Roy B, Pereira B, Bouteloup C, et al. Effect of prehabilita-tion in gastro-oesophageal adenocarcinoma: Study protocol of a multicentric, randomised, control trial—the PREHAB study. BMJ Open. 2016; 6(12): e012876. Submit your article to this journal | https://openventio.org/submit-manuscript/ Charalabopoulos A, et al
Baker A, Wooten LA, Malloy M. Nutritional considerations after gastrectomy and esophagectomy for malignancy. Curr Treat Options Oncol. 2011; 12(1): 85-95. doi: 10.1007/s11864-010-0134-0
Durrand JW, Batterham AM, Danjoux GR. Pre-habilitation (i): Aggregation of marginal gains. Anaesthesia. 2014; 69(5): 403-406. doi: 10.1111/anae.12666 e3
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gastro (GOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.